Volume 48, Number 9, 457-460, DOI: 10.1007/s10038-003-0060-0

BglII gene polymorphism of the a2ß1 integrin gene is a risk factor for diabetic retinopathy in Caucasians with type 2 diabetes

MojcaGlobočnik Petrovič, Marko Hawlina, Borut Peterlin and Daniel Petrovič

View Related Documents

Abstract

Platelets are thought to be involved in the pathogenesis of diabetic retinopathy. The BglII gene polymorphism of the agr2beta1 integrin, which is a platelet collagen receptor, has been suggested as a genetic risk factor for diabetic retinopathy in Japanese subjects. The aim of this study was to look for a relationship between the BglII gene polymorphism of the agr2beta1 integrin gene and the development of diabetic retinopathy in Caucasians with type 2 diabetes. Subjects with type 2 diabetes and diabetic retinopathy (n=163) were compared with diabetic subjects without diabetic retinopathy (n=95). A significantly higher frequency of the BglII (+/+) genotype of the gene polymorphism of the agr2beta1 integrin gene was found in patients with diabetic retinopathy compared with patients without diabetic retinopathy (19.6% vs 7.4%; P=0.008). The present study demonstrates that the BglII (+/+) genotype of the gene polymorphism of the agr2beta1 integrin gene is an independent risk factor (odds ratio: 2.4, 95% confidence interval 1.0–6.0; P<0.05) for diabetic retinopathy in Caucasians with type 2 diabetes.

Keywords  BglII gene polymorphism of the agr2beta1 integrin - Diabetic retinopathy - Type 2 diabetes - Association study - Genetic risk factor

Fulltext Preview

Image of the first page of the fulltext document